ASX Share rice
Tue 04 Aug 2020 - 07:00:am (Sydney)

AVE Share Price

AVECHO BIOTECHNOLOGY LIMITEDAVEPharmaceuticals, Biotechnology & Life Sciences

AVE Company Information


Avecho Biotechnology Limited






2A Westall Road Melbourne VIC Australia 3168


61 3 9002 5000

COO & GM of Animal Health & Nutrition:

Dr. Roksan Libinaki

CEO & Chief Scientific Officer:

Dr. Paul Gavin

Company Sec. & CFO:

Ms. Melanie Leydin

Company Overview:

Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.

AVE Share Price Information

Shares Issued:


Market Capitalisation:


Revenue (TTM):


Revenue Per Share (TTM):


Earnings per Share:


Profit Margin:


Operating Margin (TTM):


Return On Assets (TTM):


Return On Equity (TTM):


Quarterly Revenue Growth (YOY):


Gross Profit(TTM):


Diluted Earnings Per Share (TTM):


AVE CashFlow Statement

CashFlow Date:




Change To Liabilities:


Total Cashflow From Investing Activities:


Net Borrowings:


Net Income:


Total Cash From Operating Activities:




Other Cashflow From Investing Activities:


Change To Inventory:


Change To Account Receivables:


Capital Expenditures:


AVE Income Statement

Income Date:


Income Before Tax:


Net Income:


Gross Profit:


Operating Income:


Other Operating Expenses:


Interest Expense:


Total Revenue:


Total Operating Expenses:


Cost Of Revenue:


AVE Balance Sheet

Balance Sheet Date:


Intangible Assets:


Total Liabilities:


Total Stockholder Equity:


Other Current Liabilities:


Total Assets:


Common Stock:


Other Current Assets:


Retained Earnings:


Other Liabilities:




Total Current Liabilities:


Property - Plant & Equipment:


Net Tangible Assets:


Total Current Assets:


Net Receivables:


Short-Term Investments:




Accounts Payable:


Non Currrent Assets (Other):


Short-Term Investments:


Non Current Liabilities Total:


AVE Share Price History

AVE News

17 Apr, 2020
Avecho Biotechnology's's (ASX:AVE) stock is up by a considerable 200% over the past month. Given the company's...
14 Jan, 2020
Ross Murdoch has been the CEO of Avecho Biotechnology Limited (ASX:AVE) since 2015. This analysis aims first to...
12 Nov, 2019
Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we...